PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25925N0290Increase RMR molecular thyroid reference testing — Cytopath Biopsy Lab Inc

Cytopath Biopsy Lab Inc holds $5.9M across 72 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C25921A0060. Competition previously drew 3 offers. Set-aside status: NONE. Recompete timing centers on the Sep 24, 2026 PoP end — agencies typically plan 12–18 months ahead.

Network Contract Office 19 (36C259)
Awarding office
Cytopath Biopsy Lab Inc
Recipient
Sep 24, 2026
PoP end
$40K
Obligated
$120K
Potential
621511
NAICS
Q301
PSC
NONE
Set-aside
3 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Cytopath Biopsy Lab Inc — $90

Contract facts

NONE
Contract number36C25925N0290
Also listed as36C259-25-N-0290
Also listed as36C25921A0060-36C25925N0290
AgencyNetwork Contract Office 19 (36C259)
Awarding officeNetwork Contract Office 19 (36C259)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentCytopath Biopsy Lab Inc
CAGE7ASS1
UEIKC5VWAGMNLT6
NAICS621511

No full NAICS 621511 intel page yet. Browse NAICS intelligence

PSCQ301
Parent IDIQ / IDV36C25921A0060
Place of performancePORT CHESTER NY
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
PoP startSep 25, 2025
PoP end (current)Sep 24, 2026
Obligated$40K
Current value$120K
Potential value$120K

INCREASE RMR MOLECULAR THYROID REFERENCE TESTING CALL ORDER TO FUND YEAR 5 is a federal NONE award for Network Contract Office 19 (36C259) held by Cytopath Biopsy Lab Inc. Estimated value $120K ($40K obligated). Current period of performance ends Sep 24, 2026. Last award drew 3 bidders. Place of performance: PORT CHESTER NY.

INCREASE RMR MOLECULAR THYROID REFERENCE TESTING CALL ORDER TO FUND YEAR 5

Recompete timing

Public
Expiring in 34 days

Current PoP ends Sep 24, 2026 (34 days remaining). Agencies typically plan 12–18 months ahead — at 1.1 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Cytopath Biopsy Lab Inc$5.9M obligated across 72 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)
Department of Veterans Affairs (VA)$5.9M · 100% of firm total
Open full company profile

Related awards

Same parent · incumbent
36C24125N0751
THYROID TESTING LAB SERVICE
$300K
Sep 29, 2026
36C24626N0170
THYROSEQ
$100K
Sep 30, 2026
36C25026P0252
THYROSEQ V3 GENOMIC CLASSIFIER (GC) TESTING
$146K
Dec 28, 2026
36C24223N0352
THYROSEQUENCE TESTING SERVICE
$360K
Feb 12, 2028
36C24225N0344
THYROSEQUENCE TESTING SERVICE
$120K
Feb 12, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C25925N0290?

36C25925N0290 (Increase RMR molecular thyroid reference testing) is a Network Contract Office 19 (36C259) award with a potential value of $120K, currently held by Cytopath Biopsy Lab Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C259-25-N-0290?

36C259-25-N-0290 is the dashed form of PIID 36C25925N0290 (Increase RMR molecular thyroid reference testing), held by Cytopath Biopsy Lab Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25925N0290?

Network Contract Office 19 (36C259) awarded 36C25925N0290 to Cytopath Biopsy Lab Inc (potential $120K).

Who is the incumbent on 36C25925N0290?

Cytopath Biopsy Lab Inc is the incumbent with $5.9M across 72 related awards in SCOUT’s public footprint. The current period of performance ends Sep 24, 2026.

When does Cytopath Biopsy Lab Inc’s 36C25925N0290 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 24, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C25925N0290